The Cooper Companies, Inc. (BVMF:C1OO34)

Market Cap	67.47B -24.3%
Revenue (ttm)	21.07B +6.1%
Net Income	1.17B -43.1%
EPS	5.90 -42.8%
Shares Out	n/a
PE Ratio	57.45
Forward PE	14.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21
Open	34.90
Previous Close	n/a
Day's Range	34.90 - 34.98
52-Week Range	29.00 - 47.00
Beta	0.89
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 15,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: C1OO34

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD